<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-sodium-chloride.xml</id>
  <title>Recalls Watch: Sodium Chloride</title>
  <link rel="self" href="https://recalls.watch/feed/substance-sodium-chloride.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-11-04T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/100073/</id>
    <title>Eagle Pharma Outsourcing LLC: PHENYLephrine HCL Infusion and 1 more</title>
    <link href="https://recalls.watch/recall/fda/100073/"/>
    <updated>2026-11-04T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99712/</id>
    <title>Sterling Pharmaceutical Services LLC: AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% and 8 more</title>
    <link href="https://recalls.watch/recall/fda/99712/"/>
    <updated>2026-09-30T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-par-health-issues-voluntary-nationwide-recall-two-lots-dexmedetomidine-hcl-09-so/</id>
    <title>Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter</title>
    <link href="https://recalls.watch/recall/fda/n-par-health-issues-voluntary-nationwide-recall-two-lots-dexmedetomidine-hcl-09-so/"/>
    <updated>2026-09-18T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of particulate matter identified as cellulose or stopper material</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-otsuka-icu-medical-llc-issues-voluntary-nationwide-recall-09-sodium-chloride-inj/</id>
    <title>Otsuka ICU Medical LLC Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection, USP Due To a Product Mix-up with 10 mEq Potassium Chloride Injection</title>
    <link href="https://recalls.watch/recall/fda/n-otsuka-icu-medical-llc-issues-voluntary-nationwide-recall-09-sodium-chloride-inj/"/>
    <updated>2026-09-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Product mix-up where 0.9% Sodium Chloride Injection, USP overwrap may contain 10 mEq Potassium Chloride Injection</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99703/</id>
    <title>B BRAUN MEDICAL INC: 0.9% Sodium Chloride Injection</title>
    <link href="https://recalls.watch/recall/fda/99703/"/>
    <updated>2026-09-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99678/</id>
    <title>Baxter Healthcare Corporation: 0.9% Sodium Chloride Injection USP 500 mL</title>
    <link href="https://recalls.watch/recall/fda/99678/"/>
    <updated>2026-09-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of particulate matter: Particulates identified as fiberglass</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99500/</id>
    <title>Baxter Healthcare Corporation: Vancomycin Injection and 16 more</title>
    <link href="https://recalls.watch/recall/fda/99500/"/>
    <updated>2026-09-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-b-braun-medical-inc-issues-voluntary-nationwide-recall-09-sodium-chloride-inject/</id>
    <title>B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter</title>
    <link href="https://recalls.watch/recall/fda/n-b-braun-medical-inc-issues-voluntary-nationwide-recall-09-sodium-chloride-inject/"/>
    <updated>2026-09-03T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of particulate matter identified as iron oxide</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-baxter-issues-voluntary-nationwide-recall-two-lots-09-sodium-chloride-injection-/</id>
    <title>Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate Matter</title>
    <link href="https://recalls.watch/recall/fda/n-baxter-issues-voluntary-nationwide-recall-two-lots-09-sodium-chloride-injection-/"/>
    <updated>2026-08-25T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Potential presence of particulate matter identified as fiberglass in the solution.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98693/</id>
    <title>B BRAUN MEDICAL INC: Sterile Water for Injection USP and 3 more</title>
    <link href="https://recalls.watch/recall/fda/98693/"/>
    <updated>2026-04-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98724/</id>
    <title>Huons Co., Ltd.: Lidocaine HCl injection and 3 more</title>
    <link href="https://recalls.watch/recall/fda/98724/"/>
    <updated>2026-04-22T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98581/</id>
    <title>Fresenius Kabi USA, LLC: 0.45% Sodium Chloride Injection and 13 more</title>
    <link href="https://recalls.watch/recall/fda/98581/"/>
    <updated>2026-04-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98391/</id>
    <title>Fresenius Kabi Compounding, LLC: acyclovir sodium and 4 more</title>
    <link href="https://recalls.watch/recall/fda/98391/"/>
    <updated>2026-02-18T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97841/</id>
    <title>Otsuka ICU Medical LLC: 0.9% SODIUM CHLORIDE Injection</title>
    <link href="https://recalls.watch/recall/fda/97841/"/>
    <updated>2025-11-05T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: Potential for flexible container leaks.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97641/</id>
    <title>IntegraDose Compounding Services LLC: Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use</title>
    <link href="https://recalls.watch/recall/fda/97641/"/>
    <updated>2025-10-22T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97477/</id>
    <title>B BRAUN MEDICAL INC: STERILE WATER FOR INJECTION USP and 1 more</title>
    <link href="https://recalls.watch/recall/fda/97477/"/>
    <updated>2025-09-24T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97433/</id>
    <title>B BRAUN MEDICAL INC: Lactated Ringers's Injection USP and 1 more</title>
    <link href="https://recalls.watch/recall/fda/97433/"/>
    <updated>2025-09-10T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter Presence of Particulate Matter.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97368/</id>
    <title>B BRAUN MEDICAL INC: Lactated Ringer's Injection USP and 1 more</title>
    <link href="https://recalls.watch/recall/fda/97368/"/>
    <updated>2025-08-20T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-b-braun-medical-issues-voluntary-nationwide-recall-lactated-ringers-injection-us/</id>
    <title>B. Braun Medical Issues Voluntary Nationwide Recall of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL Due to the Presence of Particulate Matter</title>
    <link href="https://recalls.watch/recall/fda/n-b-braun-medical-issues-voluntary-nationwide-recall-lactated-ringers-injection-us/"/>
    <updated>2025-08-19T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Due to the presence of particulate matter.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97059/</id>
    <title>B BRAUN MEDICAL INC: 0.9% Sodium Chloride Injection USP</title>
    <link href="https://recalls.watch/recall/fda/97059/"/>
    <updated>2025-07-02T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96877/</id>
    <title>Fresenius Medical Care Holdings, Inc.: 0.9% Sodium Chloride Injection</title>
    <link href="https://recalls.watch/recall/fda/96877/"/>
    <updated>2025-07-02T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96607/</id>
    <title>Denver Solutions, LLC DBA Leiters Health: Glycopyrrolate and 4 more</title>
    <link href="https://recalls.watch/recall/fda/96607/"/>
    <updated>2025-04-30T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: Leaking/damaged syringes.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96470/</id>
    <title>Dr. Reddy's Laboratories, Inc.: Levetiracetam 0.75% in Sodium Chloride Injection 1</title>
    <link href="https://recalls.watch/recall/fda/96470/"/>
    <updated>2025-04-23T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96605/</id>
    <title>B. Braun Medical Inc: 0.9% Sodium chloride Irrigation USP</title>
    <link href="https://recalls.watch/recall/fda/96605/"/>
    <updated>2025-04-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96419/</id>
    <title>Nephron Sterile Compounding Center LLC: Sodium Chloride Injection 9%</title>
    <link href="https://recalls.watch/recall/fda/96419/"/>
    <updated>2025-03-19T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96307/</id>
    <title>Central Admixture Pharmacy Services, Inc.: PHENYLephrine added to 0.9% sodium chloride</title>
    <link href="https://recalls.watch/recall/fda/96307/"/>
    <updated>2025-03-19T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-dr-reddys-issues-nationwide-recall-levetiracetam-075-sodium-chloride-injection-1/</id>
    <title>Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag</title>
    <link href="https://recalls.watch/recall/fda/n-dr-reddys-issues-nationwide-recall-levetiracetam-075-sodium-chloride-injection-1/"/>
    <updated>2025-03-13T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Mislabeling of infusion bag</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-central-admixture-pharmacy-services-caps-issues-nationwide-recall-phenylephrine-/</id>
    <title>Central Admixture Pharmacy Services (CAPS) Issues Nationwide Recall of Phenylephrine 40 mg Added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bags Due to Visible Black Particulate Matter in a Single-Sealed Vial</title>
    <link href="https://recalls.watch/recall/fda/n-central-admixture-pharmacy-services-caps-issues-nationwide-recall-phenylephrine-/"/>
    <updated>2025-02-24T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Due to visible black particulate matter</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95993/</id>
    <title>Hikma Injectables USA Inc: ketamine inj 50 mg per 1 mL and 1 more</title>
    <link href="https://recalls.watch/recall/fda/95993/"/>
    <updated>2025-01-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95427/</id>
    <title>Fresenius Kabi Compounding, LLC: Phenylephrine HCl 0.9% Sodium Chloride Injection USP and 9 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=95427"/>
    <updated>2024-10-30T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP violations cGMP violations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95035/</id>
    <title>B. Braun Medical Inc: 0.9% Sodium Chloride Injection USP</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=95035"/>
    <updated>2024-08-28T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-b-braun-issues-voluntary-nationwide-recall-09-sodium-chloride-injection-usp-1000/</id>
    <title>B. Braun Medical Inc.: B Braun: 0.9% Sodium Chloride for Injection USP 1000 mL in E3 containers</title>
    <link href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/b-braun-issues-voluntary-nationwide-recall-09-sodium-chloride-injection-usp-1000-ml-e3-containers"/>
    <updated>2024-08-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Potential for particulate matter and fluid leakage of the containers</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94522/</id>
    <title>Hikma Injectables USA Inc: Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94522"/>
    <updated>2024-05-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93456/</id>
    <title>SCA Pharmaceuticals, LLC: Diltiazem HCl 125 mg in 0.9% Sodium Chloride Injection and 31 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93456"/>
    <updated>2024-04-03T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93710/</id>
    <title>Denver Solutions, LLC DBA Leiters Health: FentaNYL citrate PF and 5 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93710"/>
    <updated>2024-02-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93265/</id>
    <title>Exela Pharma Sciences LLC: 8.4% Sodium Bicarbonate Injection and 2 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93265"/>
    <updated>2023-11-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter: Silicone</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/91788/</id>
    <title>Akorn, Inc.: Atropine Sulfate Ophthalmic Solution and 85 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=91788"/>
    <updated>2023-06-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Firm went out of business and could no longer continue stability studies.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/90948/</id>
    <title>Akorn, Inc.: AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic Ointment USP and 26 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=90948"/>
    <updated>2023-01-25T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations:</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/91113/</id>
    <title>ICU Medical Inc: 0.9% Sodium Chloride Injection</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=91113"/>
    <updated>2022-11-23T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.</summary>
  </entry>
</feed>
